The effects of growth hormone status on circulating levels of vascular growth factors

Clinical Endocrinology

Volumn 63, Issue 1, 2005, Pages 79-86

  Silha, Josef V ^a   Krsek, Michal ^b   Hana, Vaclav ^b   Marek, Josef ^b   Weiss, Vladimir ^b   Jezkova, Jana ^b   Rosicka, Martina ^b   Jarkovska, Zuzana ^b   Murphy, Liam J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOPOIETIN 2; ENDOSTATIN; GROWTH FACTOR; GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D;

ACROMEGALY; ADULT; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM INJURY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION;

ACROMEGALY; ADULT; ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANGIOPOIETIN-2; ENDOSTATINS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MENOPAUSE; MIDDLE AGED; RIBONUCLEASE, PANCREATIC; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 22044448927     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02303.x     Document Type: Article

References (46)

1. Moulton, K.S., Olsen, B.R., Sonn, S., Fukai, N., Zurakowski, D. & Zeng, X. (2004) Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation, 110, 1330-1336.
2. Morishita, R., Nakamura, S., Hayashi, S., Aoki, M., Matsushita, H., Tomita, N., Yamamoto, K., Moriguchi, A., Higaki, J. & Ogihara, T. (1998) Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease. Journal of Atherosclerosis and Thrombosis, 4, 128-134.
3. Yoshitomi, Y., Kojima, S., Umemoto, T., Kubo, K., Matsumoto, Y., Yano, M., Sugi, T. & Kuramochi, M. (1999) Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. Journal of Clinical Endocrinology and Metabolism, 84, 2425-2428.
4. Nishimura, M., Ikeda, T., Ushiyama, M., Nanbu, A., Kinoshita, S. & Yoshimura, M. (1999) Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. Journal of Clinical Endocrinology and Metabolism, 84, 659-662.
5. Lim, H.S., Blann, A.D., Chong, A.Y., Freestone, B. & Lip, G.Y. (2004) Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care, 27, 2918-2924.
6. Nakajima, K., Tabata, S., Yamashita, T., Kusuhara, M., Arakawa, K., Ohmori, R., Yonemura, A., Higashi, K., Ayaori, M., Nakamura, H. & Ohsuzu, F. (2004) Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease. Clinical Cardiology, 27, 281-286.
7. Hutter, R., Sauter, B.V., Reis, E.D., Roque, M., Vorchheimer, D., Carrick, F.E., Fallon, J.T., Fuster, V. & Badimon, J.J. (2003) Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation, 107, 1658-1663.
8. Burgmann, H., Hollenstein, U., Maca, T., Zedwitz-Liebenstein, K., Thalhammer, F., Koppensteiner, R., Ehringer, H. & Graninger, W. (1996) Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. Journal of Clinical Pathology, 49, 508-510.
9. Chiarelli, F., Pomilio, M., Mohn, A., Tumini, S., Verrotti, A., Mezzetti, A., Cipollone, F., Wasniewska, M., Morgese, G. & Spagnoli, A. (2002) Serum angiogenin concentrations in young patients with diabetes mellitus. European Journal of Clinical Investigation, 32, 110-114.
10. Irving, R.J., Carson, M.N., Webb, D.J. & Walker, B.R. (2002) Peripheral vascular structure and function in men with contrasting GH levels. Journal of Clinical Endocrinology and Metabolism, 87, 3309-3314.
11. Oomen, P.H., Beentjes, J.A., Bosma, E., Smit, A.J., Reitsma, W.D. & Dullaart, R.P. (2002) Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement. Clinical Endocrinology, 56, 519-524.
12. Smith, J.C., Evans, L.M., Wilkinson, I., Goodfellow, J., Cockcroft, J.R., Scanlon, M.F. & Davies, J.S. (2002) Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clinical Endocrinology, 56, 493-501.
13. Elhadd, T.A., Abdu, T.A., Oxtoby, J., Kennedy, G., McLaren, M., Neary, R., Belch, J.J. & Clayton, R.N. (2001) Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 4223-1232.
14. Capaldo, B., Guardasole, V., Pardo, F., Matarazzo, M., Di Rella, F., Numis, F., Merola, B., Longobardi, S. & Sacca, L. (2001) Abnormal vascular reactivity in growth hormone deficiency. Circulation, 103, 520-524.
15. Schiavon, F., Maffei, P., Martini, C., De Carlo, E., Fais, C., Todesco, S. & Sicolo, N. (1999) Morphologic study of microcirculation in acromegaly by capillaroscopy. Journal of Clinical Endocrinology and Metabolism, 84, 3151-3155.
16. Krsek, M., Prazny, M., Marek, J., Skrha, J., Justova, V. & Lacinova, Z. (2002) The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients. Growth Hormone and IGF Research, 12, 54-59.
17. Rizzoni, D., Porteri, E., Giustina, A., De Ciuceis, C., Sleiman, I., Boari, G.E., Castellano, M., Muiesan, M.L., Bonadonna, S., Burattin, A., Cerudelli, B. & Agabiti-Rosei, E. (2004) Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension, 43, 561-565.
18. Aloia, J.F. & Graver, R.W. (1976) Dermal changes in osteoporosis following prolonged treatment with human growth hormone. Journal of Cutaneous Pathology, 3, 222-231.
19. Thorey, I.S., Hinz, B., Hoeflich, A., Kaesler, S., Bugnon, P., Elmlinger, M., Wanke, R., Wolf, E. & Werner, S. (2004) Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation. Journal of Biological Chemistry, 279, 26674-26684.
20. Hana, V., Silha, J.V., Justova, V., Lacinova, Z., Stepan, J.J. & Murphy, L.J. (2004) The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clinical Endocrinology, 60, 442-450.
21. Mathews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419.
22. Maison, P., Demolis, P., Young, J., Schaison, G., Giudicelli, J.F. & Chanson, P. (2000) Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clinical Endocrinology, 53, 445-451.
23. Deckers, M.M., Karperien, M., van der Bent, C., Yamashita, T., Papapoulos, S.E. & Lowik, C.W. (2000) Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology, 141, 1667-1674.
24. Moenner, M., Gusse, M., Hatzi, E. & Badet, J. (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. European Journal of Biochemistry, 226, 483-489.
25. Olson, K.A., Verselis, S.J. & Fett, J.W. (1998) Angiogenin is regulated in vivo as an acute phase protein. Biochemical and Biophysical Research Communications, 242, 480-483.
26. Folkman, J. & Klagsbrun, M. (1987) Angiogenic factors. Science, 235, 442-447.
27. Skovseth, D.K., Veuger, M.J., Sorensen, D.R., De Angelis, P.M. & Haraldsen, G. (2005) Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis and perivascular cell recruitment in vivo. Blood, 105, 1044-1051.
28. Bates, A.S., Van't Hoff, W., Jones, P.J. & Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169-1172.
29. DeBoer, H., Blok, G.J. & van der Veen, E.A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
30. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
31. Papalambros, E., Sigala, F., Georgopoulos, S., Panou, N., Kavatzas, N., Agapitos, M. & Bastounis, E. (2004) Vascular endothelial growth factor and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with plaque destabilization via neovascularization. Cerebrovascular Disease, 18, 160-165.
32. Rabinovsky, E.D. & Draghia-Akli, R. (2004) Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Molecular Therapies, 9, 46-55.
33. Ruberte, J., Ayuso, E., Navarro, M., Carretero, A., Nacher, V., Haurigot, V., George, M., Llombart, C., Casellas, A., Costa, C., Bosch, A. & Bosch, F. (2004) Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. Journal of Clinical Investigation, 113, 1149-1157.
34. Nagai, Y., Ando, H., Nohara, E., Yamashita, H., Takamura, T. & Kobayashi, K. (2000) Plasma levels of vascular endothelial growth factor in patients with acromegaly. Hormone and Metabolic Research, 32, 326-329.
35. Randeva, H.S., Lewandowski, K.C., Komorowski, J., Murray, R.D., O'Callaghan, C.J., Hillhouse, E.W., Stepien, H. & Shalet, S.M. (2004) Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Circulation, 109, 2405-2410.
36. Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.S. & Isner, J.M. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. American Journal of Pathology, 153, 381-394.
37. Marconcini, L., Marchio, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F. & Oliviero, S. (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proceeding of the National Academy of Sciences of the United States of America, 96, 9671-9676.
38. Tang, Y., Zhang, D., Fallavollita, L. & Brodt, P. (2003) Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Research, 63, 1166-1171.
39. Currie, M.J., Hanrahan, V., Gunningham, S.P., Morrin, H.R., Frampton, C., Han, C., Robinson, B.A. & Fox, S.B. (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. Journal of Clinical Pathology, 57, 829-834.
40. Kou, B., Li, Y., Zhang, L., Zhu, G., Wang, X., Li, Y., Xia, J. & Shi, Y. (2004) In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment. Experimental and Molecular Pathology, 76, 129-137.
41. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N. & Yancopoulos, G.D. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
42. Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. & Comoglio, P.M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. Journal of Cell Biology, 119, 629-641.
43. Skrtic, S., Wallenius, V., Ekberg, S., Brenzel, A., Gressner, A.M. & Jansson, J.O. (1997) Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology, 138, 4683-4689.
44. Sato, T., Yoshinouchi, T., Sakamoto, T., Fujieda, H., Murao, S., Sato, H., Kobayashi, H. & Ohe, T. (1997) Hepatocyte growth factor (HGF): new biochemical marker for acute myocardial infarction. Heart Vessels, 12, 241-246.
45. Yamamoto, Y., Kohara, K., Tabara, Y. & Miki, T. (2001) Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor. Journal of Hypertension, 19, 1975-1979.
46. Colao, A., Spiezia, S., Cerbone, G., Pivonello, R., Marzullo, P., Ferone, D., Di Somma, C., Assanti, A.P. & Lombardi, G. (2001) Increased arterial intima-media thickness by B-M mode echo-doppler ultrasonography in acromegaly. Clinical Endocrinology, 54, 515-524.